Board Meeting Details
- Date: Thursday, November 5, 2026
- Purpose: To consider and approve two key agenda items
Agenda Items
1. Approval of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026
2. Consideration of proposal for raising funds through issuance of one or more instruments including:
- Equity shares
- Convertible securities
- Via Preferential Issue or any other suitable mode
- Determination of price and other modalities
Trading Window Closure
- Previously intimated via letter dated September 26, 2026
- Closed for all Designated Persons and their immediate relatives
- Closure period: From Thursday, October 1, 2026 until 48 hours after declaration of financial results
- Specific end date: November 7, 2026 (both days inclusive)
- Basis: SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct